UPS
46
5
NI
65
3
GIS
54
2
CSX
50
3
CMCSA
50
4
AFL
62
2
SRCL
68
-3
AAP
24
4
SYK
60
-10
GWW
46
-4
ABT
57
7
DG
32
2
HUM
35
6
XEL
50
2
MCD
44
5
SEE
41
-3
GILD
38
12
NUE
40
3
NKE
48
5
ROK
48
-2
UPS
46
5
NI
65
3
GIS
54
2
CSX
50
3
CMCSA
50
4
AFL
62
2
SRCL
68
-3
AAP
24
4
SYK
60
-10
GWW
46
-4
ABT
57
7
DG
32
2
HUM
35
6
XEL
50
2
MCD
44
5
SEE
41
-3
GILD
38
12
NUE
40
3
NKE
48
5
ROK
48
-2
Financhill
Back

Par Pacific Holdings Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
15

PARR
Par Pacific Holdings

Last Price:
23.83
Seasonality Move:
2.33%
Sell
38

RARE
Ultragenyx Pharmaceutical

Last Price:
39.58
Seasonality Move:
3.65%
Sell
15
Par Pacific Holdings (PARR) is a Sell

Is Par Pacific Holdings a Buy, Sell or Hold?

  • The current Par Pacific Holdings [PARR] share price is $24.58. The Score for PARR is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.
  • PARR is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
38
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $38.02. The Score for RARE is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PARR Stock Price Chart

What is Par Pacific Holdings's stock price today?

  • The Par Pacific Holdings share price today is $24.58
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PARR is experiencing slight selling pressure.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $38.02
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing slight buying pressure.

PARR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.32 Sell
Relative Strength Index (14 RSI): 29.78 Sell
Chaikin Money Flow: -134655 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (24.84 - 27.78) Sell
Bollinger Bands (100): (28.29 - 38.33) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.74 Sell
Relative Strength Index (14 RSI): 40.05 Sell
Chaikin Money Flow: 76134 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (39.06 - 42.34) Sell
Bollinger Bands (100): (41.13 - 48.85) Sell

PARR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 24.87 Sell
20-day SMA: 25.77 Sell
50-day SMA: 28.93 Sell
200-day SMA: 33.72 Sell
8-day EMA: 24.89 Sell
20-day EMA: 25.91 Sell
50-day EMA: 28.65 Sell
200-day EMA: 31.72 Sell

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.68 Sell
20-day SMA: 40.48 Sell
50-day SMA: 42.18 Sell
200-day SMA: 42.45 Sell
8-day EMA: 39.81 Sell
20-day EMA: 40.64 Sell
50-day EMA: 42.13 Sell
200-day EMA: 43.5 Sell

Par Pacific Holdings Earnings Growth & PARR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $1.86 per share, an increase next quarter of $0.09 per share, a decrease this year of $4.67 per share, and a decrease next year of $0.19 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.

Par Pacific Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):